Month: June 2018

enzymes FAAH

Fatty Acid Amide Hydrolase (FAAH) Inhibitor – an enzyme with novel therapeutic potential

Jun 22, 2018• Articles, Business Consultant, Pharma Consultant

Read More →
hepatic encephalopathy

Hepatic Encephalopathy- An ailment of liver to brain

Jun 21, 2018• Articles

Hepatic Encephalopathy (HE) can be described as deterioration of brain function occurring due to accumulation of toxic substances in the...

Read More →

NF-κB Inhibitors- A Promising Future

Jun 18, 2018• Articles, Pharma Consultant

NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) is a protein transcription factor that can orchestrate complex...

Read More →
transthyretin amyloidosis

Notizia

Jun 14, 2018• Notizia, Pharma Consultant

Read More →
transthyretin amyloidosis

Notizia

Jun 7, 2018• Business Consultant, Notizia, Pharma Consultant

Axovant rely on new gene therapy, Rise in Shares  Roivant Neuro Company has licensed Oxford Biomedica’s gene therapy OXB-102, now...

Read More →
↑
Close
Trending Posts
Sections